April 30, 2019
Sinovant Sciences net approval of Derazantinib’s Clinical Trial Application by the China National Medical Products Administration
Chinese registrational clinical trial for derazantinib to begin in 2H 2019 BURLINGTON, Mass.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24ARQL&src=ctag” target=”_blank”gt;$ARQLlt;/agt; lt;a href=”https://twitter.com/hashtag/arql?src=hash” target=”_blank”gt;#arqllt;/agt;–ArQule, Inc.’s…